Skip to content

Evaluation of the effect of food intake on improving sleep

Evaluation of the effect of food intake on improving sleep - Evaluation of the effect of food intake on improving sleep

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056168
Enrollment
76
Registered
2025-09-19
Start date
2024-12-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Oral ingestion of the test food for 4 weeks Oral ingestion of the placebo food for 4 weeks

Sponsors

Morinaga & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females aged over 20 to under 60 when informed consent. 2) Suibjects who are dissatisfied with their sleep in daily life 3) Subjects who fully understand the purpose and content of the research and agree to participate in the research of their own free will

Exclusion criteria

Exclusion criteria: Subjects 1)with an irregular lifestyle. 2) engaged in manual labor such as day/night shifts, late night shifts, or heavy lifting, and those with irregular lifestyles. 3) unsuitable due to their alcohol consumption habits. 4) unsuitable due to their suitability to wear measurement equipment. 5) with an environment that interferes with sleep at bedtime. 6) suspected of, under treatment for, or with a history of sleep apnea syndrome (SAS). 7) who have or are suspected to have nocturia, benign prostatic hyperplasia, or overactive bladder. 8) with or with a history of chronic fatigue syndrome, psychiatric disorders, hypertension, or serious diseases. 9) who have difficulty in carrying out questionnaire, etc., based on pre-test. 10) who may have major depression based on pre-test major depression episode results. 11) who are pregnant, lactating, possibly pregnant during the pre-test, or who wish to become pregnant during the study. 12) taking pharmaceuticals (quasi-drugs) that may affect sleep and fatigue during the pre-test. 13) using health foods that claim effects on sleep and fatigue during the pre-test. 14) in the habit of consuming foods, pharmaceuticals, or quasi-drugs containing ingredients involved in the test food at least once a week. 15) with hay fever requiring medication. 16) with diseases requiring constant medication, under treatment, or with a serious disease or past history requiring medication. 17) who have participated in other clinical trials within the month prior to the pre-test or who wish to participate in other studies during the study period. 18) whose measurements during the pre-test significantly deviate from the reference range. 19) who may develop allergic symptoms to drugs or foods. 20) planning to change their lifestyle during the study period. 21) judged inappropriate based on lifestyle questionnaire results. 22) judged inappropriate based on the responsible physician's judgment.

Design outcomes

Primary

MeasureTime frame
Sleep and fatigue assessment

Secondary

MeasureTime frame
Lifestyle assessment using a diary

Countries

Japan

Contacts

Public ContactTakumi Yamaguchi

Morinaga & Co., Ltd. Health Science and Research Center, R&D institute

t-yamaguchi-bc@morinaga.co.jp045-571-6140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 26, 2026